Bioventus, Inc. (BVS)
8.58
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 16:00
8.59
+0.01
(+0.12%)
After-Hours: 20:00
Bioventus EPS Diluted (Quarterly) : 0.0458 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1888 |
| Boston Scientific Corp. | 0.4493 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.006M |
| Revenue (Quarterly) | 138.65M |
| Total Expenses (Quarterly) | 135.50M |
| Enterprise Value | 914.82M |
| Gross Profit Margin (Quarterly) | 66.95% |
| Profit Margin (Quarterly) | 2.89% |
| Earnings Yield | 1.31% |
| Operating Earnings Yield | 8.33% |
| Normalized Earnings Yield | 1.834 |